METFORMIN ER 500 MG

METFORMIN ER 500 MG was reported 303373 times

These side effects are most commonly reported by patients taking METFORMIN ER 500 MG:

# Side effect Count
0 NAUSEA 19980
1 DIARRHOEA 19245
2 BLOOD GLUCOSE INCREASED 17094
3 DRUG INEFFECTIVE 16576
4 FATIGUE 15270
5 ACUTE KIDNEY INJURY 14487
6 VOMITING 13365
7 LACTIC ACIDOSIS 13095
8 OFF LABEL USE 12393
9 DYSPNOEA 11754
10 WEIGHT DECREASED 11012
11 DIZZINESS 10830
12 HEADACHE 10494
13 PAIN 10353
14 MALAISE 9170
15 ASTHENIA 9034
16 FALL 8108
17 ARTHRALGIA 7825
18 DECREASED APPETITE 7802
19 DEATH 6835
20 PAIN IN EXTREMITY 6662
21 PNEUMONIA 6352
22 ABDOMINAL PAIN 6189
23 RASH 6101
24 INJECTION SITE PAIN 6097
25 TOXICITY TO VARIOUS AGENTS 6016
26 COUGH 5985
27 PRURITUS 5979
28 HYPOGLYCAEMIA 5824
29 CONSTIPATION 5800
30 HYPOTENSION 5740
31 ABDOMINAL PAIN UPPER 5358
32 WEIGHT INCREASED 5333
33 CONDITION AGGRAVATED 5325
34 DRUG INTERACTION 5306
35 PYREXIA 5282
36 HYPERTENSION 5180
37 RENAL FAILURE 5113
38 BACK PAIN 5013
39 DEHYDRATION 4950
40 ANXIETY 4914
41 METABOLIC ACIDOSIS 4903
42 INSOMNIA 4624
43 URINARY TRACT INFECTION 4592
44 ABDOMINAL DISCOMFORT 4389
45 FEELING ABNORMAL 4335
46 CONFUSIONAL STATE 4318
47 BLOOD PRESSURE INCREASED 4317
48 ANAEMIA 4261
49 DIABETES MELLITUS 4240
50 INCORRECT DOSE ADMINISTERED 4190
51 GAIT DISTURBANCE 4185
52 BLOOD GLUCOSE DECREASED 4121
53 GLYCOSYLATED HAEMOGLOBIN INCREASED 4117
54 DEPRESSION 4113
55 PERIPHERAL SWELLING 4075
56 CHRONIC KIDNEY DISEASE 4057
57 CHEST PAIN 4004
58 SOMNOLENCE 3927
59 DRUG DOSE OMISSION 3642
60 MUSCLE SPASMS 3640
61 DIABETIC KETOACIDOSIS 3618
62 NASOPHARYNGITIS 3596
63 PRODUCT DOSE OMISSION ISSUE 3577
64 ALOPECIA 3566
65 MYOCARDIAL INFARCTION 3549
66 CEREBROVASCULAR ACCIDENT 3493
67 MYALGIA 3432
68 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3298
69 HYPERKALAEMIA 3198
70 TREMOR 3165
71 COVID-19 3161
72 HYPERGLYCAEMIA 3009
73 HYPERHIDROSIS 2965
74 VISUAL IMPAIRMENT 2949
75 DYSPEPSIA 2881
76 OVERDOSE 2877
77 MEMORY IMPAIRMENT 2867
78 PRODUCT USE IN UNAPPROVED INDICATION 2860
79 PRODUCT USE ISSUE 2831
80 ATRIAL FIBRILLATION 2815
81 MUSCULAR WEAKNESS 2799
82 HYPOAESTHESIA 2767
83 INJECTION SITE HAEMORRHAGE 2763
84 VISION BLURRED 2748
85 OEDEMA PERIPHERAL 2741
86 PSORIASIS 2708
87 COMPLETED SUICIDE 2688
88 PARAESTHESIA 2654
89 GENERAL PHYSICAL HEALTH DETERIORATION 2652
90 DRUG HYPERSENSITIVITY 2639
91 ABDOMINAL DISTENSION 2621
92 ERYTHEMA 2620
93 LOSS OF CONSCIOUSNESS 2563
94 RENAL IMPAIRMENT 2552
95 SEPSIS 2539
96 INFLUENZA 2524
97 JOINT SWELLING 2488
98 ASTHMA 2484
99 PANCREATITIS 2452
100 SYNCOPE 2443
101 DIABETES MELLITUS INADEQUATE CONTROL 2427
102 PALPITATIONS 2385
103 HYPERSENSITIVITY 2363
104 URTICARIA 2362
105 GASTROOESOPHAGEAL REFLUX DISEASE 2328
106 HEART RATE INCREASED 2300
107 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2225
108 PRODUCT QUALITY ISSUE 2134
109 BLOOD CREATININE INCREASED 2133
110 GASTROINTESTINAL HAEMORRHAGE 2133
111 CHEST DISCOMFORT 2122
112 GASTROINTESTINAL DISORDER 2103
113 ARTHRITIS 2098
114 HAEMOGLOBIN DECREASED 2084
115 INFECTION 2078
116 NEUROPATHY PERIPHERAL 2040
117 CARDIAC ARREST 2028
118 BLADDER CANCER 2015
119 INTENTIONAL PRODUCT MISUSE 2003
120 TACHYCARDIA 1973
121 SINUSITIS 1965
122 CHILLS 1946
123 TYPE 2 DIABETES MELLITUS 1933
124 BALANCE DISORDER 1924
125 OROPHARYNGEAL PAIN 1919
126 CATARACT 1918
127 INTENTIONAL PRODUCT USE ISSUE 1906
128 PULMONARY EMBOLISM 1897
129 CARDIAC FAILURE 1858
130 RHEUMATOID ARTHRITIS 1858
131 BLOOD GLUCOSE ABNORMAL 1851
132 CARDIAC FAILURE CONGESTIVE 1842
133 UNDERDOSE 1834
134 HYPONATRAEMIA 1831
135 IMPAIRED GASTRIC EMPTYING 1801
136 CONTUSION 1791
137 INTENTIONAL OVERDOSE 1786
138 DRY MOUTH 1783
139 STRESS 1775
140 DYSPHAGIA 1774
141 INJECTION SITE MASS 1727
142 INJECTION SITE BRUISING 1724
143 CARDIAC DISORDER 1717
144 RESPIRATORY FAILURE 1646
145 FLUSHING 1641
146 FLATULENCE 1625
147 BRONCHITIS 1621
148 WHEEZING 1616
149 DYSGEUSIA 1612
150 DRUG INTOLERANCE 1604
151 SWELLING 1580
152 BRADYCARDIA 1531
153 PLATELET COUNT DECREASED 1528
154 ILLNESS 1524
155 POLLAKIURIA 1514
156 MUSCULOSKELETAL STIFFNESS 1502
157 SLEEP DISORDER 1501
158 INJECTION SITE ERYTHEMA 1500
159 MOBILITY DECREASED 1498
160 SHOCK 1496
161 RHABDOMYOLYSIS 1464
162 EUGLYCAEMIC DIABETIC KETOACIDOSIS 1461
163 HOT FLUSH 1449
164 PRODUCT DOSE OMISSION 1448
165 CELLULITIS 1430
166 THROMBOCYTOPENIA 1420
167 RHINORRHOEA 1419
168 OXYGEN SATURATION DECREASED 1418
169 SEIZURE 1413
170 BLOOD PRESSURE DECREASED 1409
171 HEPATIC ENZYME INCREASED 1407
172 NEUTROPENIA 1401
173 MEDICATION ERROR 1369
174 RENAL FAILURE ACUTE 1368
175 OSTEOARTHRITIS 1357
176 DRY SKIN 1351
177 WHITE BLOOD CELL COUNT DECREASED 1347
178 EPISTAXIS 1343
179 DISEASE PROGRESSION 1340
180 PRODUCTIVE COUGH 1338
181 PANCREATITIS ACUTE 1337
182 BLOOD CHOLESTEROL INCREASED 1334
183 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1334
184 INJECTION SITE PRURITUS 1329
185 NEPHROLITHIASIS 1329
186 MIGRAINE 1314
187 HOSPITALISATION 1308
188 VERTIGO 1299
189 HYPOKALAEMIA 1292
190 MUSCULOSKELETAL PAIN 1289
191 DEVICE ISSUE 1278
192 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1274
193 THROMBOSIS 1259
194 LETHARGY 1245
195 SWELLING FACE 1228
196 BLOOD PRESSURE SYSTOLIC INCREASED 1226
197 BURNING SENSATION 1223
198 SKIN EXFOLIATION 1218
199 CHOLELITHIASIS 1200
200 SUICIDE ATTEMPT 1190
201 KETOACIDOSIS 1180
202 HAEMATOCHEZIA 1177
203 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1176
204 ADVERSE DRUG REACTION 1168
205 AMNESIA 1164
206 FUNGAL INFECTION 1161
207 DISCOMFORT 1159
208 HALLUCINATION 1159
209 NECK PAIN 1158
210 ACCIDENTAL OVERDOSE 1157
211 AGITATION 1155
212 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1155
213 NASAL CONGESTION 1149
214 LOWER RESPIRATORY TRACT INFECTION 1146
215 FEELING HOT 1145
216 DYSPNOEA EXERTIONAL 1138
217 DYSPHONIA 1137
218 HAEMORRHAGE 1130
219 ALANINE AMINOTRANSFERASE INCREASED 1129
220 DEEP VEIN THROMBOSIS 1122
221 TREATMENT NONCOMPLIANCE 1118
222 BLISTER 1117
223 INFLUENZA LIKE ILLNESS 1116
224 ARTHROPATHY 1113
225 MALIGNANT NEOPLASM PROGRESSION 1113
226 EMOTIONAL DISTRESS 1110
227 RENAL DISORDER 1105
228 DYSURIA 1104
229 RECTAL HAEMORRHAGE 1104
230 DYSARTHRIA 1094
231 DEVICE MALFUNCTION 1093
232 BLOOD GLUCOSE FLUCTUATION 1092
233 ACUTE MYOCARDIAL INFARCTION 1088
234 FOETAL EXPOSURE DURING PREGNANCY 1088
235 RENAL INJURY 1085
236 TREATMENT FAILURE 1085
237 SUICIDAL IDEATION 1075
238 CORONARY ARTERY DISEASE 1074
239 MATERNAL EXPOSURE DURING PREGNANCY 1048
240 RASH PRURITIC 1036
241 INFUSION RELATED REACTION 1035
242 PLEURAL EFFUSION 1029
243 C-REACTIVE PROTEIN INCREASED 1025
244 HAEMATURIA 1020
245 COMA 1019
246 SEPTIC SHOCK 1015
247 LUNG DISORDER 1013
248 ANGIOEDEMA 1011
249 PULMONARY OEDEMA 1004
250 DEPRESSED MOOD 1003
251 INJECTION SITE NODULE 1001
252 FLUID RETENTION 988
253 HYPOMAGNESAEMIA 986
254 NERVOUSNESS 981
255 ANGINA PECTORIS 980
256 MULTIPLE ORGAN DYSFUNCTION SYNDROME 979
257 GAIT INABILITY 978
258 OEDEMA 968
259 ARRHYTHMIA 964
260 CYSTITIS 964
261 DRUG LEVEL INCREASED 962
262 INJECTION SITE SWELLING 961
263 PSORIATIC ARTHROPATHY 960
264 THERAPY INTERRUPTED 960
265 HEPATIC STEATOSIS 957
266 HERPES ZOSTER 950
267 END STAGE RENAL DISEASE 934
268 ERUCTATION 928
269 FEBRILE NEUTROPENIA 925
270 HEART RATE DECREASED 925
271 DISTURBANCE IN ATTENTION 923
272 ELECTROCARDIOGRAM QT PROLONGED 919
273 HYPOTHYROIDISM 911
274 BONE PAIN 909
275 DEVICE LEAKAGE 909
276 WHITE BLOOD CELL COUNT INCREASED 903
277 TRANSIENT ISCHAEMIC ATTACK 899
278 THERAPY CESSATION 898
279 INFLAMMATION 895
280 PANCYTOPENIA 894
281 HYPOPHAGIA 878
282 CONTRAINDICATED PRODUCT ADMINISTERED 871
283 SKIN DISCOLOURATION 870
284 DISORIENTATION 863
285 TUBULOINTERSTITIAL NEPHRITIS 860
286 SPEECH DISORDER 855
287 EYE PAIN 852
288 TINNITUS 850
289 ASPARTATE AMINOTRANSFERASE INCREASED 847
290 SWOLLEN TONGUE 840
291 UPPER RESPIRATORY TRACT INFECTION 835
292 STOMATITIS 834
293 COGNITIVE DISORDER 833
294 BLINDNESS 830
295 DRUG-INDUCED LIVER INJURY 827
296 URINARY RETENTION 826
297 URINARY INCONTINENCE 816
298 BLOOD PRESSURE FLUCTUATION 815
299 PRODUCT SUBSTITUTION ISSUE 810
300 ADVERSE EVENT 808
301 BLOOD POTASSIUM DECREASED 808
302 DEPRESSED LEVEL OF CONSCIOUSNESS 802
303 HYPOXIA 792
304 LIP SWELLING 792
305 SKIN ULCER 788
306 HYPOACUSIS 782
307 NO ADVERSE EVENT 780
308 EXTRA DOSE ADMINISTERED 778
309 INJURY 772
310 EATING DISORDER 771
311 IRRITABILITY 758
312 PRODUCT STORAGE ERROR 757
313 UNEVALUABLE EVENT 756
314 DYSSTASIA 753
315 APHASIA 749
316 WOUND 743
317 INTESTINAL OBSTRUCTION 739
318 OSTEOPOROSIS 739
319 NEEDLE ISSUE 738
320 MENTAL STATUS CHANGES 734
321 HEAD INJURY 733
322 SLEEP APNOEA SYNDROME 731
323 FREQUENT BOWEL MOVEMENTS 729
324 LOCALISED INFECTION 729
325 ANAPHYLACTIC REACTION 725
326 DRUG EFFECT DECREASED 714
327 LIMB INJURY 712
328 THROAT IRRITATION 712
329 DISEASE RECURRENCE 708
330 DIVERTICULITIS 708
331 CARDIO-RESPIRATORY ARREST 707
332 LEUKOCYTOSIS 704
333 DELIRIUM 702
334 EXPOSURE DURING PREGNANCY 700
335 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 699
336 THERAPEUTIC PRODUCT EFFECT DECREASED 687
337 BLOOD TRIGLYCERIDES INCREASED 685
338 OBESITY 682
339 GASTRITIS 679
340 INJECTION SITE EXTRAVASATION 679
341 UNRESPONSIVE TO STIMULI 679
342 ILL-DEFINED DISORDER 678
343 INJECTION SITE REACTION 676
344 NIGHTMARE 676
345 THERAPEUTIC RESPONSE UNEXPECTED 672
346 PANCREATIC CARCINOMA 670
347 THERAPEUTIC RESPONSE DECREASED 670
348 THIRST 668
349 BLOOD CREATINE PHOSPHOKINASE INCREASED 667
350 IMPAIRED HEALING 665
351 EYE IRRITATION 661
352 ANURIA 658
353 ROAD TRAFFIC ACCIDENT 658
354 EYE DISORDER 657
355 LIVER DISORDER 656
356 HYPERLACTACIDAEMIA 649
357 LIMB DISCOMFORT 646
358 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 641
359 MELAENA 636
360 GLOMERULAR FILTRATION RATE DECREASED 632
361 COLITIS 629
362 HEPATIC CIRRHOSIS 628
363 LIVER FUNCTION TEST ABNORMAL 624
364 NIGHT SWEATS 622
365 COLITIS ULCERATIVE 620
366 CEREBRAL HAEMORRHAGE 619
367 INTERNATIONAL NORMALISED RATIO INCREASED 619
368 ACCIDENTAL UNDERDOSE 618
369 PRODUCT PRESCRIBING ERROR 616
370 GASTRIC DISORDER 614
371 RED BLOOD CELL COUNT DECREASED 612
372 SURGERY 610
373 VISUAL ACUITY REDUCED 610
374 HAEMATOMA 607
375 HAEMOPTYSIS 607
376 HAEMATEMESIS 606
377 PEMPHIGOID 603
378 ECZEMA 602
379 MOVEMENT DISORDER 602
380 FEELING COLD 597
381 EYE SWELLING 596
382 BLOOD LACTIC ACID INCREASED 593
383 MENTAL DISORDER 592
384 SKIN LESION 588
385 BLOOD POTASSIUM INCREASED 586
386 DIABETIC NEUROPATHY 586
387 ACUTE RESPIRATORY FAILURE 585
388 INTERVERTEBRAL DISC PROTRUSION 585
389 ENCEPHALOPATHY 584
390 TASTE DISORDER 584
391 DRY EYE 583
392 DYSKINESIA 583
393 CIRCULATORY COLLAPSE 581
394 PULMONARY FIBROSIS 581
395 RASH ERYTHEMATOUS 579
396 SUSPECTED SUICIDE 578
397 AGEUSIA 576
398 INCORRECT DOSE ADMINISTERED BY DEVICE 573
399 OBSTRUCTIVE AIRWAYS DISORDER 573
400 BLOOD URINE PRESENT 572
401 NEOPLASM MALIGNANT 571
402 PRESYNCOPE 565
403 HAIR COLOUR CHANGES 564
404 RESPIRATORY DISTRESS 564
405 HYPOCALCAEMIA 563
406 INTERSTITIAL LUNG DISEASE 563
407 UPPER GASTROINTESTINAL HAEMORRHAGE 563
408 PALLOR 558
409 AGGRESSION 556
410 DRUG EFFECT INCOMPLETE 556
411 HYPERSOMNIA 555
412 BREAST CANCER 553
413 HYPOTHERMIA 553
414 ORTHOSTATIC HYPOTENSION 551
415 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 550
416 JAUNDICE 545
417 FIBROMYALGIA 543
418 HEPATIC FAILURE 543
419 FEEDING DISORDER 541
420 TACHYPNOEA 537
421 DRUG ABUSE 536
422 HEMIPARESIS 535
423 ACIDOSIS 533
424 BLOOD PRESSURE ABNORMAL 531
425 GOUT 531
426 SINUS DISORDER 531
427 BODY TEMPERATURE DECREASED 530
428 HEART RATE IRREGULAR 530
429 RESTLESSNESS 529
430 IMPAIRED QUALITY OF LIFE 527
431 RETCHING 524
432 SNEEZING 521
433 HAIR TEXTURE ABNORMAL 520
434 HIP FRACTURE 518
435 JOINT INJURY 518
436 INCREASED APPETITE 516
437 GLAUCOMA 513
438 RENAL TUBULAR NECROSIS 512
439 THERAPY NON-RESPONDER 512
440 IMPAIRED WORK ABILITY 510
441 VIRAL INFECTION 510
442 CARDIOGENIC SHOCK 509
443 FAECES DISCOLOURED 509
444 LYMPHADENOPATHY 508
445 CORONARY ARTERY OCCLUSION 506
446 EAR INFECTION 506
447 EXPIRED PRODUCT ADMINISTERED 505
448 FULL BLOOD COUNT ABNORMAL 504
449 CROHN^S DISEASE 503
450 NEPHROGENIC ANAEMIA 503
451 SYNOVITIS 502
452 BLOOD SODIUM DECREASED 500
453 NEURALGIA 500
454 VITAMIN B12 DEFICIENCY 500
455 OSTEOMYELITIS 499
456 RASH MACULAR 499
457 DEMENTIA 498
458 DIPLOPIA 498
459 SCIATICA 492
460 ACCIDENTAL EXPOSURE TO PRODUCT 491
461 OCULAR HYPERAEMIA 491
462 GASTROENTERITIS 489
463 ERECTILE DYSFUNCTION 488
464 PSYCHOLOGICAL TRAUMA 488
465 BLOOD UREA INCREASED 484
466 STAPHYLOCOCCAL INFECTION 483
467 HYPOVOLAEMIA 480
468 CHROMATURIA 479
469 POOR QUALITY SLEEP 476
470 WITHDRAWAL SYNDROME 474
471 LACRIMATION INCREASED 473
472 BLOOD PRESSURE DIASTOLIC DECREASED 472
473 PANIC ATTACK 472
474 SKIN DISORDER 472
475 HUNGER 467
476 KIDNEY INFECTION 467
477 NODULE 467
478 IRRITABLE BOWEL SYNDROME 466
479 ABDOMINAL PAIN LOWER 465
480 JOINT STIFFNESS 464
481 SYSTEMIC LUPUS ERYTHEMATOSUS 464
482 POLYURIA 463
483 RIB FRACTURE 463
484 PNEUMONIA ASPIRATION 461
485 VAGINAL HAEMORRHAGE 460
486 MENTAL IMPAIRMENT 457
487 ORAL PAIN 456
488 ALTERED STATE OF CONSCIOUSNESS 455
489 ASCITES 455
490 HAIR DISORDER 455
491 ABNORMAL BEHAVIOUR 453
492 LEUKOPENIA 453
493 NEUTROPHIL COUNT DECREASED 452
494 SINUS CONGESTION 451
495 ACNE 447
496 GAMMA-GLUTAMYLTRANSFERASE INCREASED 446
497 TOOTHACHE 446
498 RESPIRATORY TRACT INFECTION 445
499 PERICARDIAL EFFUSION 444
500 HAEMATOCRIT DECREASED 443
501 EYE PRURITUS 441
502 RESPIRATORY DISORDER 441
503 HAEMORRHOIDS 439
504 PREMATURE BABY 438
505 INTENTIONAL DOSE OMISSION 437
506 MADAROSIS 437
507 SKIN BURNING SENSATION 437
508 GASTRIC ULCER 435
509 ANGER 433
510 HYPERLIPIDAEMIA 432
511 ISCHAEMIC STROKE 432
512 ABNORMAL LOSS OF WEIGHT 431
513 CRYING 431
514 PROCEDURAL PAIN 431
515 MIDDLE INSOMNIA 430
516 PRURITUS GENERALISED 430
517 RESPIRATORY TRACT CONGESTION 430
518 HEPATITIS 429
519 HYPOKINESIA 429
520 EJECTION FRACTION DECREASED 428
521 PROSTATE CANCER 428
522 CANDIDA INFECTION 426
523 CARDIOVASCULAR DISORDER 425
524 BLOOD ALKALINE PHOSPHATASE INCREASED 424
525 COORDINATION ABNORMAL 424
526 LIVER FUNCTION TEST INCREASED 422
527 CARPAL TUNNEL SYNDROME 421
528 BLOOD IRON DECREASED 419
529 PAIN IN JAW 419
530 VENTRICULAR TACHYCARDIA 419
531 UROSEPSIS 418
532 COLD SWEAT 417
533 SENSORY LOSS 414
534 HERNIA 412
535 ARTERIOSCLEROSIS 411
536 HEMIPLEGIA 411
537 LIVER INJURY 411
538 DRUG WITHDRAWAL SYNDROME 410
539 FOURNIER^S GANGRENE 408
540 BLOOD BILIRUBIN INCREASED 407
541 DRUG ADMINISTRATION ERROR 407
542 EAR PAIN 406
543 PULMONARY MASS 404
544 INJECTION SITE RASH 402
545 EYE HAEMORRHAGE 401
546 ABNORMAL DREAMS 400
547 EOSINOPHILIA 400
548 HALLUCINATION, VISUAL 400
549 HEPATOTOXICITY 400
550 MULTIPLE SCLEROSIS RELAPSE 400
551 BLOOD MAGNESIUM DECREASED 398
552 GASTROINTESTINAL HYPOMOTILITY 398
553 COAGULOPATHY 396
554 DRUG LEVEL ABOVE THERAPEUTIC 396
555 THROAT TIGHTNESS 396
556 SOPOR 394
557 PSYCHOTIC DISORDER 393
558 PULMONARY HYPERTENSION 392
559 ANHEDONIA 391
560 ELECTROLYTE IMBALANCE 391
561 MOOD ALTERED 389
562 VASCULITIS 389
563 MUSCULOSKELETAL CHEST PAIN 388
564 PROTEINURIA 387
565 NOCTURIA 386
566 METASTASES TO LIVER 385
567 ARTERIOSCLEROSIS CORONARY ARTERY 384
568 PNEUMONITIS 383
569 SKIN HAEMORRHAGE 383
570 GASTROENTERITIS VIRAL 382
571 BASAL CELL CARCINOMA 380
572 GLOSSODYNIA 380
573 FEELING JITTERY 379
574 WRONG TECHNIQUE IN DRUG USAGE PROCESS 378
575 CHOLECYSTITIS 376
576 FEMUR FRACTURE 376
577 HAEMODYNAMIC INSTABILITY 376
578 MOTOR DYSFUNCTION 376
579 PERICARDITIS 376
580 PRODUCT ADMINISTRATION ERROR 375
581 RASH GENERALISED 375
582 ABSCESS 374
583 LABORATORY TEST ABNORMAL 374
584 ARTERIAL OCCLUSIVE DISEASE 372
585 DIABETIC METABOLIC DECOMPENSATION 371
586 FEAR 371
587 INJECTION SITE URTICARIA 371
588 MUSCLE TWITCHING 371
589 DEAFNESS 370
590 LIPASE INCREASED 368
591 LUNG NEOPLASM MALIGNANT 368
592 CHOKING 367
593 SINUS TACHYCARDIA 366
594 FOOT FRACTURE 364
595 GALLBLADDER DISORDER 364
596 MUCOSAL INFLAMMATION 363
597 UPPER LIMB FRACTURE 363
598 MYOPATHY 362
599 ABASIA 361
600 LOCAL SWELLING 361
601 MITRAL VALVE INCOMPETENCE 361
602 MYOCARDIAL ISCHAEMIA 361
603 ROTATOR CUFF SYNDROME 361
604 BODY HEIGHT DECREASED 360
605 DRUG DEPENDENCE 358
606 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 357
607 PLASMA CELL MYELOMA 357
608 GANGRENE 355
609 BLOOD COUNT ABNORMAL 354
610 CEREBRAL INFARCTION 354
611 RHINITIS 354
612 THERAPEUTIC RESPONSE SHORTENED 354
613 TRANSAMINASES INCREASED 354
614 BACK DISORDER 353
615 PHARYNGITIS 353
616 EPILEPSY 351
617 NEUTROPHIL COUNT INCREASED 350
618 FLANK PAIN 348
619 INCORRECT DRUG ADMINISTRATION DURATION 348
620 NEOPLASM PROGRESSION 348
621 MUSCULOSKELETAL DISCOMFORT 347
622 BRONCHIECTASIS 345
623 ANAL INCONTINENCE 344
624 PAIN OF SKIN 344
625 ULCER 344
626 DRUG DOSE OMISSION BY DEVICE 342
627 MASS 342
628 CARDIAC MURMUR 340
629 SEDATION 340
630 MUSCLE ATROPHY 339
631 BLINDNESS UNILATERAL 338
632 HIATUS HERNIA 337
633 NEPHROPATHY 337
634 TOOTH DISORDER 337
635 PRESCRIBED UNDERDOSE 336
636 BURSITIS 335
637 RESTLESS LEGS SYNDROME 334
638 DIABETIC RETINOPATHY 332
639 JOINT RANGE OF MOTION DECREASED 332
640 PROSTATIC SPECIFIC ANTIGEN INCREASED 332
641 CHOLESTASIS 331
642 RASH MACULO-PAPULAR 331
643 RED BLOOD CELL SEDIMENTATION RATE INCREASED 329
644 PAROSMIA 328
645 DRUG PRESCRIBING ERROR 326
646 PARKINSONISM 326
647 SPUTUM DISCOLOURED 326
648 RASH PAPULAR 325
649 INJURY ASSOCIATED WITH DEVICE 324
650 AFFECT LABILITY 323
651 HEAD DISCOMFORT 322
652 RALES 322
653 INTENTIONAL DEVICE MISUSE 321
654 PRESCRIBED OVERDOSE 320
655 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 319
656 TOOTH INFECTION 318
657 ACUTE CORONARY SYNDROME 317
658 HYPERCALCAEMIA 316
659 SKIN IRRITATION 316
660 THYROID DISORDER 316
661 ANKLE FRACTURE 315
662 BACK INJURY 315
663 NERVOUS SYSTEM DISORDER 315
664 KNEE ARTHROPLASTY 313
665 WEIGHT FLUCTUATION 313
666 BODY TEMPERATURE INCREASED 312
667 INCORRECT PRODUCT STORAGE 312
668 MOOD SWINGS 312
669 PARKINSON^S DISEASE 312
670 RENAL PAIN 312
671 HYPERTENSIVE CRISIS 311
672 CARDIOMEGALY 310
673 COVID-19 PNEUMONIA 310
674 ABORTION SPONTANEOUS 309
675 MUSCLE SPASTICITY 309
676 DECREASED ACTIVITY 308
677 HYPOGLYCAEMIC COMA 308
678 LEFT VENTRICULAR DYSFUNCTION 308
679 TENDONITIS 305
680 IRON DEFICIENCY ANAEMIA 304
681 CARDIOMYOPATHY 303
682 DEVICE DELIVERY SYSTEM ISSUE 303
683 INCORRECT PRODUCT ADMINISTRATION DURATION 303
684 MICTURITION URGENCY 303
685 PERIPHERAL COLDNESS 302
686 PREMATURE DELIVERY 302
687 SUBDURAL HAEMATOMA 301
688 CLOSTRIDIUM DIFFICILE INFECTION 300
689 SEASONAL ALLERGY 300
690 SENSORY DISTURBANCE 300
691 CYST 299
692 PRODUCT DOSE OMISSION IN ERROR 299
693 ELECTROCARDIOGRAM ABNORMAL 298
694 FULL BLOOD COUNT DECREASED 298
695 HALLUCINATION, AUDITORY 298
696 MULTIPLE SCLEROSIS 296
697 OLIGURIA 295
698 PULMONARY CONGESTION 295
699 RESPIRATORY ARREST 295
700 RENAL CYST 294
701 GINGIVAL PAIN 293
702 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 293
703 SEROTONIN SYNDROME 293
704 ILEUS 291
705 THINKING ABNORMAL 290
706 HYPOVOLAEMIC SHOCK 289
707 MUSCLE TIGHTNESS 289
708 NERVE COMPRESSION 287
709 CONVULSION 286
710 HYPERTHYROIDISM 286
711 EXOSTOSIS 285
712 BLOOD PRESSURE DIASTOLIC ABNORMAL 284
713 ACUTE RESPIRATORY DISTRESS SYNDROME 283
714 POST PROCEDURAL COMPLICATION 283
715 VENTRICULAR FIBRILLATION 280
716 ATRIOVENTRICULAR BLOCK 279
717 DYSLIPIDAEMIA 279
718 LOWER LIMB FRACTURE 279
719 PLATELET COUNT INCREASED 279
720 SCAR 279
721 SPINAL FRACTURE 279
722 BONE DISORDER 278
723 HYPERPARATHYROIDISM SECONDARY 277
724 EMOTIONAL DISORDER 275
725 OSTEOPENIA 275
726 PRODUCT PHYSICAL ISSUE 275
727 MALIGNANT MELANOMA 274
728 MALNUTRITION 274
729 SINUS BRADYCARDIA 274
730 ACUTE HEPATIC FAILURE 272
731 FORCED EXPIRATORY VOLUME DECREASED 271
732 GENERALISED TONIC-CLONIC SEIZURE 271
733 INTERNAL HAEMORRHAGE 271
734 HYPERCHOLESTEROLAEMIA 270
735 NEUROLOGICAL SYMPTOM 270
736 LIGAMENT SPRAIN 267
737 MUSCULOSKELETAL DISORDER 267
738 PRODUCT AVAILABILITY ISSUE 267
739 APHONIA 266
740 PHARYNGEAL OEDEMA 264
741 PHOTOSENSITIVITY REACTION 264
742 SPINAL PAIN 264
743 TOE AMPUTATION 264
744 INCONTINENCE 263
745 PRODUCT ODOUR ABNORMAL 263
746 VITAMIN D DEFICIENCY 263
747 ACTIVITIES OF DAILY LIVING IMPAIRED 262
748 BACTERIAL INFECTION 262
749 DRUG ERUPTION 261
750 ORAL CANDIDIASIS 261
751 SKIN CANCER 261
752 URINE OUTPUT DECREASED 261
753 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 260
754 MOUTH ULCERATION 260
755 TOOTH ABSCESS 260
756 DIZZINESS POSTURAL 259
757 OVERWEIGHT 259
758 REBOUND ACID HYPERSECRETION 259
759 INTERVERTEBRAL DISC DEGENERATION 257
760 PHOTOPHOBIA 257
761 PRODUCT DISPENSING ERROR 257
762 HEPATIC CYTOLYSIS 256
763 IMMUNODEFICIENCY 256
764 PRODUCT ADHESION ISSUE 256
765 SCHIZOPHRENIA 256
766 SPLENOMEGALY 256
767 TENDERNESS 256
768 DELUSION 255
769 LYMPHOCYTE COUNT DECREASED 255
770 NERVE INJURY 255
771 PERSONALITY DISORDER 255
772 POLYP 255
773 GLUCOSE TOLERANCE IMPAIRED 254
774 RESPIRATORY RATE INCREASED 254
775 DERMATITIS ATOPIC 252
776 HEPATIC FUNCTION ABNORMAL 252
777 VENTRICULAR EXTRASYSTOLES 252
778 HEPATOCELLULAR INJURY 251
779 SECRETION DISCHARGE 251
780 TOOTH FRACTURE 251
781 HEPATOMEGALY 249
782 INABILITY TO AFFORD MEDICATION 249
783 PANCREATIC CARCINOMA METASTATIC 249
784 POTENTIATING DRUG INTERACTION 249
785 SALIVARY HYPERSECRETION 249
786 COLON CANCER 248
787 BRAIN FOG 247
788 DRUG DISPENSING ERROR 247
789 PARAESTHESIA ORAL 247
790 INJECTION SITE DISCOMFORT 246
791 SARS-COV-2 TEST POSITIVE 245
792 SUPRAVENTRICULAR TACHYCARDIA 245
793 WOUND INFECTION 245
794 PYELONEPHRITIS 244
795 BLOOD TEST ABNORMAL 243
796 EXERCISE TOLERANCE DECREASED 243
797 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 243
798 METASTASES TO BONE 241
799 HAEMORRHAGE INTRACRANIAL 240
800 ATRIAL FLUTTER 239
801 SMALL INTESTINAL OBSTRUCTION 239
802 SUBARACHNOID HAEMORRHAGE 239
803 ANOSMIA 238
804 LOWER GASTROINTESTINAL HAEMORRHAGE 238
805 APPLICATION SITE PAIN 237
806 BONE DENSITY DECREASED 237
807 IMMUNE-MEDIATED MYOSITIS 237
808 MYOSITIS 237
809 APPETITE DISORDER 236
810 ATELECTASIS 236
811 GASTROINTESTINAL PAIN 236
812 BLINDNESS TRANSIENT 235
813 FACE OEDEMA 235
814 TRICUSPID VALVE INCOMPETENCE 235
815 ATRIOVENTRICULAR BLOCK COMPLETE 234
816 GENERALISED OEDEMA 234
817 POOR VENOUS ACCESS 234
818 SLUGGISHNESS 234
819 LARGE INTESTINE POLYP 233
820 METASTASES TO LUNG 233
821 RETINAL DETACHMENT 233
822 ANAPHYLACTIC SHOCK 232
823 DISTRIBUTIVE SHOCK 232
824 OSTEONECROSIS OF JAW 231
825 SKIN FISSURES 231
826 BLOOD PRESSURE SYSTOLIC ABNORMAL 230
827 DERMATITIS 230
828 FAECES SOFT 230
829 MYOCARDITIS 230
830 HYPOAESTHESIA ORAL 227
831 LUNG INFECTION 227
832 MULTI-ORGAN FAILURE 227
833 ADJUSTMENT DISORDER 226
834 GLYCOSYLATED HAEMOGLOBIN DECREASED 226
835 INSURANCE ISSUE 226
836 ADRENAL INSUFFICIENCY 225
837 DEVICE BREAKAGE 225
838 DIABETIC FOOT 224
839 NEOPLASM 224
840 DEVICE DISLOCATION 222
841 HYPOPNOEA 222
842 NEPHROPATHY TOXIC 222
843 SKIN LACERATION 222
844 TROPONIN INCREASED 222
845 LEFT VENTRICULAR HYPERTROPHY 221
846 MUSCLE RIGIDITY 221
847 SPINAL OSTEOARTHRITIS 221
848 BEDRIDDEN 220
849 INJECTION SITE WARMTH 220
850 POLYNEUROPATHY 220
851 SKIN INFECTION 220
852 ASPIRATION 219
853 PARANOIA 219
854 DIALYSIS 218
855 DUODENAL ULCER 218
856 GROIN PAIN 218
857 TARDIVE DYSKINESIA 218
858 PARALYSIS 217
859 APATHY 216
860 BLOOD BICARBONATE DECREASED 216
861 SPINAL DISORDER 216
862 CAROTID ARTERY THROMBOSIS 215
863 OESOPHAGITIS 215
864 POLYDIPSIA 215
865 SCAB 215
866 ANGINA UNSTABLE 214
867 PEMPHIGUS 214
868 ANION GAP INCREASED 213
869 NEUROLOGIC NEGLECT SYNDROME 213
870 NORMOCHROMIC NORMOCYTIC ANAEMIA 213
871 IMMUNE SYSTEM DISORDER 212
872 FACIAL PARALYSIS 210
873 LARYNGITIS 210
874 CHOLECYSTECTOMY 209
875 DEVICE MECHANICAL ISSUE 209
876 MANIA 209
877 FRACTURE 208
878 NECROTISING FASCIITIS 208
879 EYE INFECTION 207
880 HAEMORRHAGIC ANAEMIA 207
881 HIDRADENITIS 207
882 INSULIN RESISTANCE 207
883 MULTIPLE FRACTURES 207
884 PULMONARY ALVEOLAR HAEMORRHAGE 207
885 APPLICATION SITE ERYTHEMA 206
886 ECONOMIC PROBLEM 206
887 MACULAR DEGENERATION 206
888 RED CELL DISTRIBUTION WIDTH INCREASED 206
889 DIVERTICULUM 205
890 HAEMODIALYSIS 205
891 PULSELESS ELECTRICAL ACTIVITY 205
892 RESPIRATORY SYMPTOM 205
893 VITAMIN D DECREASED 205
894 EMPHYSEMA 204
895 HAEMORRHAGIC STROKE 204
896 ORAL DISCOMFORT 204
897 TRANSFUSION 204
898 ORAL HERPES 203
899 TENDON RUPTURE 203
900 INJECTION SITE DISCOLOURATION 202
901 INITIAL INSOMNIA 201
902 BLOOD PRESSURE INADEQUATELY CONTROLLED 200
903 FACIAL PAIN 199
904 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 199
905 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 198
906 VITREOUS FLOATERS 198
907 AGRANULOCYTOSIS 197
908 BLOOD CHOLESTEROL ABNORMAL 197
909 FOOT DEFORMITY 197
910 INTESTINAL ISCHAEMIA 197
911 MENISCUS INJURY 197
912 NEUROLEPTIC MALIGNANT SYNDROME 197
913 SUDDEN DEATH 197
914 POISONING 196
915 FLUID OVERLOAD 195
916 METABOLIC DISORDER 195
917 CARDIAC FAILURE CHRONIC 194
918 DRUG RESISTANCE 194
919 INJECTION SITE INDURATION 194
920 LOW DENSITY LIPOPROTEIN INCREASED 194
921 SCRATCH 194
922 TOOTH LOSS 194
923 APPLICATION SITE PRURITUS 193
924 ATAXIA 193
925 HYPOPHOSPHATAEMIA 193
926 QUALITY OF LIFE DECREASED 193
927 BLOOD PRESSURE DIASTOLIC INCREASED 192
928 BREATH SOUNDS ABNORMAL 191
929 PRODUCT TASTE ABNORMAL 191
930 FURUNCLE 190
931 BLOOD CALCIUM DECREASED 189
932 BUNDLE BRANCH BLOCK LEFT 189
933 FOOD CRAVING 189
934 IMPAIRED DRIVING ABILITY 189
935 DRY THROAT 188
936 PELVIC PAIN 188
937 C-REACTIVE PROTEIN ABNORMAL 187
938 HEPATIC ENCEPHALOPATHY 187
939 RENAL CANCER 187
940 HYPERTRIGLYCERIDAEMIA 186
941 INTENTIONAL SELF-INJURY 186
942 INTRAOCULAR PRESSURE INCREASED 186
943 PSYCHOMOTOR HYPERACTIVITY 186
944 EXTRASYSTOLES 185
945 JOINT DISLOCATION 185
946 BLOOD THYROID STIMULATING HORMONE INCREASED 184
947 BRAIN INJURY 184
948 CORONARY ARTERY STENOSIS 184
949 HAND DEFORMITY 184
950 HICCUPS 184
951 NEUTROPHILIA 184
952 BLOOD LACTATE DEHYDROGENASE INCREASED 183
953 CYANOSIS 183
954 NEURITIS 182
955 OSTEONECROSIS 182
956 ATRIOVENTRICULAR BLOCK FIRST DEGREE 181
957 BACTERAEMIA 181
958 BURNS SECOND DEGREE 181
959 DEVICE DIFFICULT TO USE 181
960 HYDRONEPHROSIS 181
961 INJECTION SITE INJURY 181
962 PULMONARY THROMBOSIS 181
963 STENT PLACEMENT 181
964 CATARRH 180
965 DEVICE FAILURE 180
966 PANCREATIC DISORDER 180
967 POISONING DELIBERATE 180
968 DEVICE DEFECTIVE 179
969 GRIP STRENGTH DECREASED 179
970 SKIN REACTION 179
971 VITAMIN B12 DECREASED 179
972 CARDIAC FAILURE ACUTE 178
973 FOLLICULITIS 178
974 PRODUCT MONITORING ERROR 178
975 PRODUCT PRESCRIBING ISSUE 178
976 PULMONARY VASCULITIS 178
977 IRON DEFICIENCY 177
978 ABNORMAL FAECES 176
979 BLADDER DISORDER 176
980 FRUSTRATION TOLERANCE DECREASED 176
981 GASTROINTESTINAL INFECTION 176
982 HIP ARTHROPLASTY 176
983 INCORRECT ROUTE OF DRUG ADMINISTRATION 176
984 BOWEL MOVEMENT IRREGULARITY 175
985 DEVICE USE ISSUE 175
986 GINGIVAL BLEEDING 175
987 PRODUCT USE COMPLAINT 175
988 BLADDER TRANSITIONAL CELL CARCINOMA 174
989 SHOCK HAEMORRHAGIC 174
990 THERAPY CHANGE 174
991 WRIST FRACTURE 174
992 CLOSTRIDIUM DIFFICILE COLITIS 173
993 APHTHOUS ULCER 172
994 BRAIN OEDEMA 172
995 HEPATIC CANCER 172
996 HYPERKERATOSIS 172
997 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 172
998 ACCIDENT 171
999 CONCOMITANT DISEASE AGGRAVATED 171